MG
BSX icon

Marex Group’s Boston Scientific BSX Stock Holding History

Marex Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6,310
Closed -$343K – 1158
2026
Q1 		$396K Buy
6,310
+387
+7% +$31K ﹤0.01% 693
2025
Q4 		$565K Buy
5,923
+1,116
+23% +$109K ﹤0.01% 528
2025
Q3 		$469K Buy
+4,807
New +$498K ﹤0.01% 513
2025
Q2 		– Sell
-4,371
Closed -$441K – 684
2025
Q1 		$441K Sell
4,371
-690
-14% -$69.5K 0.01% 360
2024
Q4 		$452K Buy
5,061
+1,559
+45% +$137K 0.01% 368
2024
Q3 		$293K Hold
3,502
– – 0.01% 386
2024
Q2 		$270K Sell
3,502
-500
-12% -$36.6K 0.01% 434
2024
Q1 		$274K Sell
4,002
-170
-4% -$10.9K 0.01% 339
2023
Q4 		$241K Buy
+4,172
New +$223K 0.01% 432

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Marex Group's BSX Position: Q2 2026 in Review

Marex Group sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 6,310 shares — an estimated $343K sold.

Marex Group first reported a position in BSX in Q4 2023 and held it in 9 quarters. The position peaked at $565K in Q4 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Marex Group reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Marex Group sold 6,310 Boston Scientific shares in Q2 2026, an estimated $343K.
  • Marex Group first reported a position in Boston Scientific in Q4 2023 and held it in 9 quarters.
  • Marex Group's Boston Scientific position peaked at $565K in Q4 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.